RecruitingNot ApplicableNCT07343843

Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Effect of Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section

Sponsor

Benha University

Enrollment

52 participants

Start Date

Jan 17, 2026

Study Type

INTERVENTIONAL

Conditions

Stress Virtual Reality Dexmedetomidine Hemodynamics Maternal Anxiety Neonatal Outcomes Cesarean Section

Summary

This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria4

Age over 18 years old.
American Society of Anesthesiologists (ASA) physical status II.
Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
Provide informed consent and agree to participate in the study.

Exclusion Criteria10

Patient's refusal
Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.
Patient with psychiatric disorders.
Sensory impairment (blindness, deafness).
Any technical problem preventing proper fitting of the glasses to the patient face.
Patients with cognitive impairment, epilepsy or with claustrophobia
Patients with suspected eye infection
Signs of active labor.
Pregnancy related-diseases or antepartum hemorrhage.
Presence of Fetal distress.

Interventions

DRUGDexmedetomidine

Following confirmation of adequate spinal anesthesia, dexmedetomidine will be administered as an intravenous infusion of 0.2-0.4µg/kg/hr until abdominal closure.

OTHERVirtual reality

Participants will be fitted with virtual reality headsets immediately after the establishment of spinal anesthesia. The headsets will display calming immersive audiovisual content, and participants will continue wearing them throughout the entire procedure until skin closure.